English Korean Chinese
ホーム > 市場調査レポート > 医薬品 > 感染症 > サハラ以南アフリカの主要国における感染症向け医薬品市場
カテゴリ
医薬品 (4964)
OTC (153)
がん (943)
ドラッグデリバリー (185)
ワクチン (181)
感染症 (353)
規制環境 (132)
後発医薬品 (135)
骨疾患 (37)
処方薬 (158)
神経疾患 (174)
精神疾患 (89)
製薬企業関連 (531)
創薬 (1524)
糖尿病 (193)
動物用医薬 (17)
肥満症 (44)
市場調査レポート

サハラ以南アフリカの主要国における感染症向け医薬品市場

Key Sub-Saharan African Infectious Disease Pharmaceutical Markets

発行 Frost & Sullivan
出版日 2008年02月 商品コード 62836
ページ情報 英文 224 Pages
価格
US$ 6,000 換算 ¥ 482,820 (税抜) Web Access (Regional License)
US$ 6,500 換算 ¥ 523,055 (税抜) Hard Copy & Web Access (Regional License)


原文目次

Abstract

Research was carried out on the infectious disease pharmaceutical market in key Sub-Saharan countries namely Kenya, Nigeria and Tanzania. A thorough PESTLE (Political, Economic, Social, Technology, Legal and Environmental) analysis was established for all the countries allowing for an accurate evaluation of external factors impacting the pharmaceutical industry. Market sizes were calculated for 2006 and forecasts determined for the period 2006 to 2012. In addition, market dynamics, such as challenges, drivers and restraints were also determined.

Table of Contents

1. Infectious Disease Pharmaceutical Markets in Key Sub-Saharan African Countries

  • 1. Executive Summary
  • 2. Research Scope and Methodology
  • 3. Research SummarySlide
  • 4. Country Analysis: Nigeria
  • 5. Country Analysis: Kenya
  • 6. Country Analysis: Tanzania
  • 7. Decision Support Databases
Back to Top